Pre-excited atrial fibrillation

Also known as: Pre-excitation Syndromes / Pre-excitation syndrome / Anomalous atrioventricular excitation / Anomalous atrioventricular excitation (disorder) / Accessory Atrioventricular Bundle / Accelerated atrioventricular conduction (disorder) / Wolff-Parkinson-White syndrome congenital / Wolff-Parkinson-White syndrome / WPW syndrome / Wolff-Parkinson-White pattern (disorder) / Lown-Ganong-Levine syndrome / Lown-Ganong-Levine syndrome (disorder) / Preexcited atrial fibrillation (disorder)

Drugs
Drugs and Targets

Drug	Drug Name	Drug Description
DB01035	Procainamide	A medication used to treat life threatening ventricular arrhythmias.

Drug	Drug Name	Target	Type
DB01035	Procainamide	Sodium channel protein type 5 subunit alpha	target
DB01035	Procainamide	DNA (cytosine-5)-methyltransferase 1	target
DB01035	Procainamide	Cytochrome P450 2D6	enzyme
DB01035	Procainamide	Cholinesterase	enzyme
DB01035	Procainamide	Solute carrier family 22 member 2	transporter
DB01035	Procainamide	Solute carrier family 22 member 1	transporter
DB01035	Procainamide	Solute carrier family 22 member 3	transporter
DB01035	Procainamide	Solute carrier family 22 member 5	transporter
DB01035	Procainamide	Solute carrier family 22 member 4	transporter
DB01035	Procainamide	Potassium voltage-gated channel subfamily H member 2	target
DB01035	Procainamide	Multidrug and toxin extrusion protein 1	transporter
DB01035	Procainamide	Multidrug and toxin extrusion protein 2	transporter

Drug	Drug Name	Phase	Status	Count